DiaMedica Therapeutics Inc. (DMAC)
Across 21 earnings reports since May 05, 2021, DiaMedica Therapeutics Inc. (DMAC) has a clear post-earnings pattern. It moves ±5.64% on average after reporting and finishes higher 38.1% of the time. Its largest post-earnings gain was +14.94% (Aug 12, 2025) and its largest decline was -14.1% (Nov 12, 2025). The next earnings report is predicted for 2026-08-10 (estimated).
Earnings reactions
How DMAC moved on each past earnings report.
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±5.64%
Positive %
38.1%
Negative %
61.9%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 06, 2026 | ☽ POST | -0.31% | open_in_new |
| Mar 31, 2026 | ☽ POST | -5.17% | open_in_new |
| Nov 12, 2025 | ☽ POST | -14.1% | open_in_new |
| Aug 12, 2025 | ☽ POST | +14.94% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±5.64%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260603 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| 8-K | 20260521 | open_in_new SEC.gov |
Frequently asked about DMAC earnings
When does DiaMedica Therapeutics Inc. report earnings next? expand_more
DiaMedica Therapeutics Inc. (DMAC)'s next earnings date is estimated for 2026-08-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does DMAC stock move after earnings? expand_more
Over 21 reports, DMAC has moved an average of ±5.64% the session after earnings, closing higher 38.1% of the time.
What was DMAC's biggest post-earnings move? expand_more
DMAC's largest post-earnings gain on record was +14.94% on Aug 12, 2025, and its largest decline was -14.1% on Nov 12, 2025.
Where can I find DiaMedica Therapeutics Inc.'s SEC filings? expand_more
All of DiaMedica Therapeutics Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- ALICO, INC. (ALCO) earnings 2026-08-07
- ASCENT INDUSTRIES CO. (ACNT) earnings 2026-08-07
- Aclaris Therapeutics, Inc. (ACRS) earnings 2026-08-07
- ACV Auctions Inc. (ACVA) earnings 2026-08-07
- ADC Therapeutics SA (ADCT) earnings 2026-08-07
- ADMA BIOLOGICS, INC. (ADMA) earnings 2026-08-07
- Aeva Technologies, Inc. (AEVA) earnings 2026-08-07
- Agenus Inc. Common Stock (AGEN) earnings 2026-08-07